Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024

SELL
$32.2 - $42.44 $943,460 - $1.24 Million
-29,300 Reduced 53.47%
25,500 $821,000
Q4 2023

Feb 14, 2024

BUY
$31.87 - $40.71 $1.22 Million - $1.56 Million
38,400 Added 234.15%
54,800 $2.23 Million
Q3 2023

Nov 14, 2023

BUY
$34.17 - $42.98 $560,388 - $704,872
16,400 New
16,400 $566,000
Q1 2023

May 16, 2023

SELL
$36.5 - $48.0 $47,450 - $62,400
-1,300 Reduced 3.65%
34,300 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$37.44 - $46.51 $1.09 Million - $1.35 Million
29,000 Added 439.39%
35,600 $1.58 Million
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $3.69 Million - $5.03 Million
-87,400 Reduced 92.98%
6,600 $281,000
Q2 2022

Aug 15, 2022

BUY
$52.3 - $71.59 $1.53 Million - $2.09 Million
29,200 Added 45.06%
94,000 $5.25 Million
Q1 2022

May 16, 2022

BUY
$51.32 - $68.5 $2.45 Million - $3.27 Million
47,800 Added 281.18%
64,800 $4.02 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $413,864 - $502,656
8,800 Added 107.32%
17,000 $937,000
Q3 2021

Nov 15, 2021

SELL
$52.17 - $70.2 $912,975 - $1.23 Million
-17,500 Reduced 68.09%
8,200 $431,000
Q2 2021

Aug 11, 2021

SELL
$68.86 - $83.34 $736,802 - $891,738
-10,700 Reduced 29.4%
25,700 $1.77 Million
Q1 2021

May 17, 2021

SELL
$76.15 - $111.94 $487,360 - $716,416
-6,400 Reduced 14.95%
36,400 $2.81 Million
Q4 2020

Feb 16, 2021

SELL
$96.85 - $148.25 $629,525 - $963,625
-6,500 Reduced 13.18%
42,800 $4.24 Million
Q3 2020

Nov 16, 2020

SELL
$122.47 - $213.56 $612,350 - $1.07 Million
-5,000 Reduced 9.21%
49,300 $7 Million
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $27.7 Million - $34.5 Million
-149,400 Reduced 73.34%
54,300 $10.7 Million
Q1 2020

May 15, 2020

BUY
$143.0 - $274.03 $25 Million - $48 Million
175,100 Added 612.24%
203,700 $39.9 Million
Q4 2019

Feb 14, 2020

SELL
$146.12 - $215.82 $3.99 Million - $5.89 Million
-27,300 Reduced 48.84%
28,600 $5.92 Million
Q3 2019

Nov 14, 2019

BUY
$130.44 - $187.64 $821,772 - $1.18 Million
6,300 Added 12.7%
55,900 $8.53 Million
Q2 2019

Aug 14, 2019

SELL
$111.45 - $128.93 $18.5 Million - $21.4 Million
-166,300 Reduced 77.03%
49,600 $6.4 Million
Q1 2019

May 15, 2019

BUY
$89.61 - $117.78 $18.3 Million - $24.1 Million
204,700 Added 1827.68%
215,900 $25.4 Million
Q4 2018

Feb 14, 2019

SELL
$87.81 - $110.65 $1.1 Million - $1.38 Million
-12,500 Reduced 52.74%
11,200 $1.03 Million
Q3 2018

Nov 14, 2018

BUY
$90.63 - $120.22 $1.13 Million - $1.5 Million
12,500 Added 111.61%
23,700 $2.67 Million
Q2 2018

Aug 14, 2018

SELL
$88.4 - $105.34 $114,920 - $136,942
-1,300 Reduced 10.4%
11,200 $1.03 Million
Q1 2018

May 15, 2018

BUY
$94.51 - $120.23 $992,355 - $1.26 Million
10,500 Added 525.0%
12,500 $1.25 Million
Q3 2017

Nov 14, 2017

BUY
$73.17 - $103.47 $146,340 - $206,940
2,000
2,000 $204,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.88B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.